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This work describes a novel application of MR-guided online adaptive radiotherapy
(MRgoART) in the management of patients whom urgent palliative care is indicated
using statum-adaptive radiotherapy (STAT-ART). The implementation of STAT-ART, as
performed at our institution, is presented including a discussion of the advantages and
limitations compared to the standard of care for palliative radiotherapy on conventional
c-arm linacs. MR-based treatment planning techniques of STAT-ART for density overrides
and deformable image registration (DIR) of diagnostic CT to the treatment MR are
also addressed.
Keywords: online adaptive radiotherapy, MRgoART, MR-guidance, MRgRT, ART, MR-guided radiotherapy,
palliative radiation, deformable image registration
INTRODUCTION
The American Cancer Society estimated that annually in 2019 there are 1.76 million new cases of
cancer with 606,880 cancer deaths (1). Most cancer deaths are associated with a decreased quality
of life and painful end-of-life, likely due to loco-regional or metastatic disease progression (2, 3).
Palliative radiotherapy (RT) allows for the management of patients with advanced stage cancer.
Palliative RT directly relieves obstructions, bleeding, and cancer-related pain for patients not a
candidate for or responding to opioid medication (2–13).
As the sensitivity and accuracy of cancer detection and subsequently cancer treatments
progressively improve, the life expectancy for cancer patients is steadily rising even with metastatic
disease (3). Thus, the continued management of these patients is of great importance (3). Due to
multiple steps in standard radiation planning processes, palliative treatment may take 3–7 days
post-consultation before the first treatment fraction is performed (3). Improving the palliative RT
workflow by utilizing advanced technology to offer rapid, same day treatment can reduce the pre-
treatment time period, allowing for near-immediate pain-relief and an improved quality of life for
these patients.
The MRIdianTM cobalt and more recently released MRIdian linac (ViewRay Inc.,
Cleveland, OH) is an MR-guided radiotherapy (MRgRT) platform that integrates magnetic
resonance imaging (MRI), radiotherapy delivery, treatment planning, image registration,
and treatment record and delivery into a single unit (14, 15). The integrated approach
enables MR-guided online adaptive radiotherapy (MRgoART), where the care team designs
and delivers a treatment plan based on patient anatomy and position at the time
of treatment setup [Mittauer et al. (under review); (16, 17)]. MRgoART, or simply
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online adaptive radiotherapy (ART), offers the opportunity for
rapid and accurate palliative online adaptive radiation therapy,
i.e., statum-ART (STAT-ART).
The purpose of this work is to describe a potential paradigm
change in the management of palliative care in radiotherapy
using STAT-ART. The implementation of STAT-ART, as
performed at our institution, is presented including a discussion
of the advantages and limitations compared to the standard of
care for palliative radiotherapy performed on conventional c-
arm linacs. MR-based treatment planning techniques for density
overrides and deformable image registration (DIR) of diagnostic
CT to the treatment MR are also addressed.
CONVENTIONAL LINAC WORKFLOW FOR
URGENT PALLIATIVE TREATMENT
Conventional radiotherapy workflow utilizes a serial-based
process map. Tasks are performed through multiple applications
and platforms (i.e., PACS, simulator system, image registration
software, segmentation software, treatment planning system,
treatment delivery system, quality assurance software, record,
FIGURE 1 | Workflow of three proposed methods of STAT-ART (left) compared to the standard of care for palliative treatment as performed on a conventional c-arm
linac (right).
and verify system). Each step of the serial radiotherapy workflow
is executed by a unique stakeholder (i.e., physician, physicist,
dosimetrist, therapist).
The workflow process for conventional radiotherapy utilizing
a c-arm linac will be briefly detailed here and is displayed in
Figure 1. When a patient presents for initial consultation with
their radiation oncologist, previously acquired diagnostic scans
are reviewed at the time of consultation. Following consultation,
the patient receives a CT simulation appointment in which a
CT scan is acquired for purposes of treatment planning and
treatment setup localization. Image registration of the diagnostic
data to the planning CT scan is often performed to aid the
physician in segmentation of the target and relevant surrounding
anatomy. On the planning CT scan, the dosimetrist creates
a treatment plan which subsequently undergoes plan quality
review by the physician and physicist in addition to a quality
assurance (QA) assessment. The patient is brought in for their
treatment appointment, where x-ray based imaging is performed
to localize the patient into the position as acquired at the time of
the CT simulation, followed by radiotherapy treatment delivery.
To accelerate the radiotherapy process when a patient presents
with urgent obstructions, bleeding, and/or pain, the above
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workflow is consolidated at the potential cost of the overall
treatment plan quality. The treatment plan complexity is often
limited for palliative cases to a parallel-opposed beam geometry
with rectangular fields, defined by jaws alone rather than the use
of more sophisticated multileaf collimation (MLC). Such plans
are advantageous for simplifying other radiotherapy workflow
processes such as simulation, setup, and treatment. However,
utilizing more conformal planning and delivery techniques with
more beam angles and more sophisticated collimation schemes
can reduce dose to uninvolved organs and tissues.
As previously described, the standard of care utilizes a
workflow of acquiring a CT simulation of the patient in setup
position followed by a treatment planning session. The process
may take several hours to several days. Additional steps to
accelerate the process for urgent palliative radiotherapy include
forgoing the simulation scan and performing 2D treatment
planning based on 2D MV imaging on the radiotherapy
treatment unit and calculation of dose to an arbitrary point
within the patient. Without knowledge of spatial orientation
of the tumor in treatment position, large target margins, and
non-conformal dose distributions are required.
STAT-ART WORKFLOW FOR URGENT
PALLIATIVE TREATMENT
Overview of STAT-ART Workflow
The STAT-ART workflow takes advantage of the MRgoART
features of the MRIdian to enable efficient adaptive planning
capabilities and expedite the overall workflow [Mittauer
et al. (under review); (16, 17)]. Prior to patient arrival and
consultation, the generalized workflow (Figure 1) includes either
generation of a patient-specific pre-plan or selection of a
preexisting non-patient specific template plan. For the patient-
specific pre-plan generation, the radiation oncologist performs
segmentation of the target volume on the diagnostic dataset
followed by the medical physicist or dosimetist performing the
treatment planning (i.e., beam geometry, defining MLC aperture,
beam weight optimization, and dose normalization). Details of
the planning technique is described in the following sections.
Following consultation, the patient is setup in an arbitrary
treatment position and localized using and a 3D volumetric
balanced steady-state free precession sequence (TrueFISP)
MR scan (Figure 2) (18). A template-plan or pre-plan from
the diagnostic scan is then adapted online based on the
actual treatment geometry including updates to segmentation,
beam apertures, optimization, and/or dose normalization. A
plan quality visual inspection and calculation-based QA are
performed for plan fidelity (17), followed by treatment delivery.
The STAT-ART workflow will be dependent on institutional
resources and MRgoART staffing model, and is generally
executed in real-time by multiple staff members including
a combination of therapist(s), a medical physicist, and a
radiation oncologist.
Planning Technique
Development of the STAT-ART protocol has emphasized
efficiency. For the pre-plan generation, segmentation performed
by the radiation oncologist is kept to a minimum with only two
regions of interest requiring contouring: external or skin and
FIGURE 2 | Clinical STAT-ART case of a pelvic bony metastasis treated to 8Gy in a single fraction to the planning target volume in green. Comparison of diagnostic
CT used for pre-planning (top right) and improved gross disease visualization on the TrueFISP treatment planning MR obtained using the MRIdian (top left). The
resulting dose distribution for STAT-ART plan of a six-beam cobalt-60 dose distribution (bottom left) in comparison to a conventional plan with 10MV AP/PA beams
(bottom right). The STAT-ART plan shows a marked reduction of the high dose volume, particularly in anterior regions of normal tissues.
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a target volume. Initial planning of the pre-plan or template
plan is performed by the medical physicist or dosimetrist with
a single isocenter and 3D conformal beams defined by the MLC
(19, 20). 3D conformal planning of the pre-plan or template
plan involves defining an isocenter point of interest, inputting
beams, setting gantry angles for ideal geometry, defining theMLC
aperture, optimization of beam weights, and a Monte Carlo dose
calculation with magnetic field corrections. As previously noted,
online adaptive is then performed to make the corresponding
plan adjustments to the patient’s on table anatomy through
segmentation updates to the target and corresponding plan MLC
aperture shape and beam weight through plan re-optimization.
Typically, STAT-ART treatment plans use a six-beam
arrangement, equivalent to two gantry positions for the three
60Co sources on the MRIdian cobalt. For the MRIdian linac,
the higher dose rate has enabled comparable delivery times
to the MRIdain cobalt even with an increase in gantry
rotation required for the six-beam arrangement. Due to the
utilization of 3D conformal planning technique, STAT-ART
plans have similar delivery times to conventional AP/PA beam
arrangements while allowing for more comparatively superior
dose distributions (Figure 2).
Electron Density for MR-Based Planning
MR-based planning requires electron density information for
dose calculation purposes. We present three strategies (Figure 1)
in the STAT-ART workflow for density propagation using bulk
density overrides or deformable image registration for respective
homogenous or heterogenous dose calculations.
Bulk Density Override
For non-thoracic based anatomical sites, a single bulk density
override of the external region of interest to water can be used
for electron density propagation. In this method of STAT-ART,
a diagnostic CT scan or even a diagnostic MR scan can be
utilized as the primary dataset of the STAT-ART pre-plan. The
deformation of the CT scan to the MR scan in MRgoART
is eliminated; advantageous when large anatomical mismatches
are anticipated and therefore eliminates the need and time to
perform manual density corrections. During the online adaptive
process with a single bulk density override, the external contour
is simply defined based on the treatment MR scan, enabling an
efficient and robust method of density propagation.
Deformation of Diagnostic CT to MR of the Day
An alternative to density override(s) is to utilize electron
density information obtained from a diagnostic CT scan. In
the MRgoART workflow of the MRIdian, the pre-plan primary
dataset of the diagnostic CT scan is deformably registered to the
frame of reference of the treatment MR scan utilizing an inverse-
consistent, free-form multi-modality DIR with a similarity
metric of mutual information and regularization proportional
to the Jacobian of the deformation vector field [Mittauer
et al. (under review)].
Beyond anatomical setup differences that may require manual
density corrections, additional deformation challenges may
include a limited field of view on the diagnostic CT scan
with missing tissue information. When density corrections are
necessary during the time of adaptation, an available override
contour of air, bone, and/or soft tissue may be utilized to enable
manual electron density edits. It is recommended to input such
empty contours with pre-defined electron density of respective
air, bone, and soft tissue to the pre-plan to enable the approach of
manual electron density edits during online adaptation.
Deformation of Template CT to MR of the Day
When prior diagnostic imaging is not readily accessible, a
template plan based on the anatomical site of interest (i.e., pelvis,
abdomen, thorax, extremity, etc.) can be adapted to the patient’s
setup at the time of treatment. The alternative method of utilizing
a template plan eliminates the time for pre-plan generation, and
may be most applicable for urgent palliative cases providing
machine availability. The deformation workflow of the CT scan
to the treatment MR scan remains the same as the above method,
with larger potential for density corrections to be required.
DISCUSSION
Adoption of Hypofractionated Palliative
Care Toward Single Fraction
In a recent review of palliative radiotherapy, Rich et al.
found the adoption of a single fraction course underutilized
compared to conventional fractionated course (21), even with
recent recommendations (22–24) emphasizing a single-fraction
or short-course palliative care. The movement toward a single
fraction course for palliative radiotherapy enables two key
benefits: cost-reduction and patient time and convenience (21,
25–27). As patients with oligometastatic disease live longer, the
need for amore sophisticated, short-course planning and delivery
approach is evident over historical parallel-opposed techniques
of 30Gy in 10 fractions.
With MR linacs becoming more common place (28), the
adoption of a single fraction course with MR-guidance is a
viable approach. The STAT-ART workflow leverages existing
volumetric imaging from radiology, eliminating an additional
simulation CT. The STAT-ART technique utilizes routine clinical
MRgRT workflows, i.e., adaptive radiotherapy. Moreover, MR-
guidance enables greater confidence based on real-time image
guidance and greater dose conformality, supporting a single
fraction approach. A randomized trial comparing efficacy and
toxicity between single fraction palliative care on CT-based IGRT
vs. MR-based IGRT has yet to be conducted. While several
randomized single fraction vs. multiple fraction trials have been
carried out, the concerns of toxicities and efficacy of the 8Gy
in 1 fraction regimen still remain. Shuja et al. and Howell
et al. described utilization of 3–5 cm margin and <2 cm margin,
respectively, from the radiographic involvement for single
fraction palliative radiotherapy on conventional c-arm linac
modalities (29, 30). The superior bony metastasis visualization
combined with improved soft tissue visualization allow for
greater precision and enable the utility of a reduced margin in
MRgRT of 0.3–0.5 cm as previously demonstrated by Mittauer
et al. (16). Howell et al. specifically cited radiation oncologists’
concerns of gastrointestinal (GI) toxicities associated with 8Gy in
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a single fraction (30). The online adaptive capabilities, to visualize
adjacent organs at risk (OARs) and modify dose based on
neighboring GI OARs, combined with a smaller margin required
due to the reduction in setup uncertainty enable MR-guided
single fraction radiotherapy a clear benefit.
Furthermore, to manage the increase in the number of
oligometastatic patients, reducing the number of treatments
to fewer fractions could potentially lessen the overall burden
on hospitals, and ultimately reduce the number of machines
required per patient population.
STAT-ART at the University of
Wisconsin-Madison
Our STATART program at the University ofWisconsin-Madison
was implemented in October 2015 on the MRIdian cobalt,
and since then transitioned to the MRIdian linac. Our initial
experiences of the STAT-ART program have been briefly reported
by Hill et al. (31) and De Costa et al. (32), and includes a
retrospective review of the first 18 patients treated with STAT-
ART from October 2015 to November 2016.
The indication for STAT-ART included patients with
metastatic cancer presenting with pain, obstruction, and
bleeding. The majority of STAT-ART patients were treated with a
prescription of 8Gy in a single fraction. STAT-ART planning and
treatment delivery was typically >30min between the patient
entering and exiting the treatment vault, compared with a mean
time from CT simulation to delivery of first treatment of 29.5 h
(95% CI, 23.7–35.2) for a similar sample of urgent palliative
cases planned and treated with the conventional radiotherapy
workflow. The median delivery time of STAT-ART was 122 s (N
= 18 patients).
Excellent clinical outcomes were observed and were in line
with historical and sampled controls: pain reduction in 11 of 14
patients, improvement of obstructive symptoms in 3 of 3 patients,
and hemostasis in 1 of 1 patient. Overall, physician and patient
response to the program has been positive, as plan quality has
improved while time commitments have been comparable to
or less than a conventional simulation-and-treatment workflow.
Future efforts include characterizing the dose difference to organs
at risk and conformality metrics between STAT-ART plans and
conventional parallel-opposed beam geometries.
MR-Based Planning for Bony Metastases
MR-based treatment planning offers better soft tissue contrast for
target delineation as compared to CT simulation (16). However,
one particularly interesting finding of the STAT-ART program
has been the ability of the MRIdian TrueFISP MR sequences
used for treatment planning to identify contrast other than in
soft tissues, as shown in Figure 2 for bony metastases. Because
pre-plan contours are routinely updated to encompass disease
identified on the treatment planning MR, the ability to target
disease in bone has been invaluable.
Additional Workflow Advantages
Through performing treatment planning, contouring, image
registration, and treatment delivery on a single platform such
as the MRIdian system not only can allow for improvement in
clinical efficiency, but also possibly allow for the decrease in the
clinical errors from the use of multiple modalities and planning
systems. The MRIdian system eliminates the time and need
for treatment planning by dosimetry when utilizing template
plans. Furthermore, simulation is done in the true treatment
position on MRIdian, an advantage over conventional linac-
based RT, enabling both enhanced contrast for target delineation
and reduction of setup uncertainties.
Dose Calculation and Deformation
Considerations
There are limitations in dose calculation accuracy of STAT-
ART when performing bulk density overrides or using deformed
diagnostic CT data. For example, with a bulk density override
of water for patient anatomy of the pelvis and abdomen, the
calculation error is likely on the order of 2%; as demonstrated
by Lee et al. for pelvis with absolute dose differences ranging
0–5% inside the planning target volume for uniform density
override of water compared to dose calculated on the respective
CT scan (33). Larger magnitude of errors would present for other
anatomical sites such as thorax/lung. Here, deformation of the
diagnostic CT to the treatment MR would be more appropriate.
Electron density propagation of the diagnostic CT to the
treatment MR presents has additional uncertainties. The image
value to density conversion may not be characterized for the
energy spectrum and/or applicable CT scanner of the diagnostic
CT dataset at hand. While it may be feasible to characterize
all CT scanners in an institution’s radiology department, the
body of work would be non-trivial and not inclusive of scanners
from outside institutions for patients referred for treatment. A
potentially more practical approach would be to incorporate CT
energy-dependent image value to density table (IVDT) curves, as
inter-scanner dependences are minimal to image value variation
and on the order of acceptable dose calculation uncertainties
for palliative care. A phantom with a range density inserts can
be utilized to quantify the Hounsfield unit values as a function
of CT energy. Repeat monoenergetic CT scans over an energy
range would be acquired to benchmark the IVDT dependent
curves. During initial planning the user would then select the
respective IVDT curve based on the DICOM tag of the patient’s
diagnostic CT.
A limitation of the fidelity of the propagation of electron
density is the overall voxel resolution. Partial-voxel effects can
influence the deformable image registration quality as can
be propagated from the initial diagnostic CT scan and/or in
the resultant deformed CT, resampled in the resolution and
frame of reference of the treatment planning MR. The user
is recommended to note the influence partial-voxel effects on
deformed electron density accuracy and the potential impact on
dose calculation accuracy.
Another challenge of the deformable image registration of
the diagnostic CT to the treatment MR is the large anatomical
differences between the scans. Figure 2 highlights the posterior
anatomical deformations between the curved tabletop of the
diagnostic CT and the flat tabletop of the radiotherapy system.
Additional deformation differences may include patient arm
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position or even missing tissue due to limited field of view on
the diagnostic CT scan. All of these require review of the CT-MR
deformation and may require additional effort and time during
the online adaptive workflow to manually correct the electron
density using segmentation and overrides.
Challenges to Implementation
The STAT-ART program relies on capabilities of MRgoART.
This work has been presented based on the platform of the
MRIdian system as has been implemented at our institution.
Modified practice of STAT-ART for other systems with CT/MR
on rails or other IGRT systems can be employed. The work to
commission and to implement the deformable image registration
and dose calculation of MRgoART has been previously
described [Mittauer et al. (under review)].
There is some potential for errors to occur in the MRgoART
workflow since the plan is adapted on the fly. However,
for clinical MRgRT users, MRgoART has become a routine
part of everyday workflow (34). The MRgoART utilizes a
secondary calculation-based QA to verify plan fidelity. For
3D conformal plans this follows conventional radiotherapy
workflow as more sophisticated measurement-based QA are not
necessary if the beammodel has been appropriately characterized
and validated. Secondly, calculation-based methods have been
previously shown to be in line with measured-based QA for the
MRgoART process (17).
Another unique consideration when implementing
MRgoART and STAT-ART is the overall time the patient is
on the table in the treatment position. While the STAT-ART
process rapidly decreases the time from consultation to treatment
for these urgent palliative cases, the “table time” may be longer
due to the adaption process. Some patients may not tolerate the
20–30min on the treatment table as required for the STAT-ART
process due to symptomatic pain.
Alternative Rapid Palliative RT on
TomoTherapy
The University of Virginia have implemented a rapid palliative
radiotherapy technique using CT-based IGRT of TomoTherapy
(Accuracy Inc, Madison, WI) with their “STAT RAD” program
(2, 3). The STAT RAD workflow utilizes the on-board MVCT
capabilities of TomoTherapy to simulate the patient in treatment
position followed by rapid treatment plan generation, quality
assurance of the plan with exit dosimetry through the on-
board CT detector, and treatment delivery. Since the treatment
planning capabilities are not integrated into the simulation and
delivery console, plan generation is performed on a separate work
station, eliminating an online adaptive approach. The University
of Virginia has successfully piloted the program with 50 patient
treats reported to date in 2012 (3).
CONCLUSION
The integration of a simulator, treatment planning system, and
delivery system into a single platform enables the opportunity
of STAT-ART, a rapid-access treatment for patients presenting
with urgent palliative needs. Electron density information
for MR-based planning of STAT-ART without formal CT
simulation can be incorporated with either a bulk density
override or deformable image registration of diagnostic CT to
the treatment MR. The online adaptive features of STAT-ART
enable adaptation of a preexisting pre-plan or template plan,
reducing the time pressure for urgent palliative radiotherapy.
Another key advantage of MRgoART is the superior plan and
treatment quality as real-time plan adaptation is performed
to the anatomy at treatment compared to the simulation day
anatomy as performed in conventional radiotherapy. STAT-
ART has great potential in the management of the palliative
radiotherapy, making efficient use of both staffing time and
resources and expediting palliative care with similarly successful
clinical outcomes.
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